- Title:
-
Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic
renal cell carcinoma . - Authors:
- Source:
- Scientific Reports. 4/13/2024, p1-8. 8p.
Academic Journal
Dear user, the application need JavaScript support. Please enable JavaScript in your browser.